MV BioTherapeutics ApyraMed

MV BioTherapeutics ApyraMed ApyraVax MV BioTherapeutics ApyraMed ApyraVax MV BioTherapeutics ApyraMed ApyraVax MV BioTherapeutics ApyraMed ATP Bacteria MV BioTherapeutics ApyraMed Altered intestinal homeostasis Antibiotics administration MV BioTherapeutics ApyraMed MV BioTherapeutics ApyraMed MV BioTherapeutics ApyraMed ApyraMed mechanism Inflammation / susceptibility
to infection Secretory IgA MV BioTherapeutics ApyraMed MV BioTherapeutics ApyraMed ApyraVax Normal intestinal homeostasis​ Loss of intestinal integrity MV BioTherapeutics ApyraMed ApyraMed administration
and Apyrase mediated
ATP degradation MV BioTherapeutics ApyraMed Back to Normal intestinal homeostasis Preservation of gut barrier
integrity and intestinal function

Technology

The ApyraMed technology exploits a recombinant live biotherapeutic that promotes adaptive intestinal homeostasis. In cancer patients, it enhances immune system competence, whereas in dysbiosis safeguards the intestinal ecosystem.

MV BioTherapeutics ApyraMed